Tag Archives: angina

Vasomedical EECP® Therapy App Version 3.0 Now Available!


Vasomedical EECP® Therapy App Version 3.0 Now Available

What’s New in Version 3.0:

– Compatibility with iOS 7

– New and improved user interface

– Improved treatment locator: Find the closest EECP® Therapy centers to your home or office based on your U.S. location!

– Improved Patient questionnaire: Users may answer questions about their symptoms and lifestyle and email the answers to their physician to determine whether or not they are a good candidate for EECP® Therapy

– Improved Angina diary in the Patients section: Users may record angina attacks and email weekly summary to physician for evaluation. A useful tool to assess the effect of EECP® Therapy

-Updated the reimbursement information to year 2013 rates

Vasomedical’s EECP® Therapy App for the iPhone and iPod Touch is designed to provide patients, physicians and EECP® therapists with the information necessary for optimal EECP® therapeutic care. EECP® therapy is a noninvasive, outpatient treatment cleared by the US FDA for patients suffering angina, congestive heart failure (CHF) and other cardiac diseases. In the app, Patients may access information about the therapy as well as view videos showing the therapy systems in operation or former patients sharing their first hand knowledge of how EECP® therapy reduced or eliminated symptoms while improving their quality of life.

Physicians may obtain the latest in patient selection and treatment guidelines to ensure patient safety and satisfaction. Summaries of selected publications in peer reviewed medical journals as well as a complete bibliography for EECP® therapy is at the physicians’ or therapists’ fingertips.

Therapists can also conveniently access treatment information and guidance in the practice and art of treating various patients with the Vasomedical proprietary EECP® systems.

The easy to use locator tab provides patients and physicians with the location of EECP® treatment centers closest to their home or office.

Get The Updated App here:

Introducing EECP Therapy to Latin American Healthcare Professionals at FIME 2013

Interest in medical devices, supplies, services and healthcare cost management in Latin America brought tens of thousands of visitors to Miami this week for the Florida International Medical Exposition (FIME), filling the Miami Convention Center and the local South Beach area and hotels.

While most visitors spent their time strolling the aisles full of exhibitors in the convention center, a group of interested medical professionals attended my presentation on the “Effects of Enhanced External Counterpulsation (EECP®) Therapy on Patient Outcomes.”

The presentation and the questions that followed focused not only on the scientifically proven clinical benefits of the Therapy, but on the tremendous potential saving to the healthcare budgets that could be realized in Latin American countries if EECP Therapy was used more often instead of, or as an adjunct to, palliative invasive procedures like stenting and bypass surgery. As in the United States, the expected increase in cardiovascular diseases such as angina and congestive heart failure, already compounded by the current epidemic prevalence of diabetes in Latin America, is unsustainable financially in the future. The need for a more cost-effective treatment to meet the clinical and financial challenges for these and additional cardiovascular diseases can be met more successfully with a greater awareness, adoption and support of EECP Therapy.

I am always happy to do my part in raising awareness about this great treatment, and it didn’t hurt that I got to enjoy sun, sushi and salsa in Miami while I was there!

Tales from the Road: The American Diabetes Association

We have just wrapped up our first exhibition at the American Diabetes Association (ADA) meeting in Chicago – which was a great experience and showed us that there is more opportunity to expand the reach of EECP® Therapy than ever before!

The show lasted from June 21st through 25th and was well attended with approximately 14,000 attendees from across the United States and around the world. The Vasomedical booth had a steady flow of interested attendees, and we spent a great deal of time educating attendees about EECP Therapy and the benefits it can have for patients.

The people we spoke with were fascinated to learn that EECP Therapy can provide relief to patients with angina symptoms such as chest or atypical pain, shortness of breath and fatigue, among others. This event was so relevant to our business because many patients with diabetes also have ischemic heart disease and can experience angina symptoms despite being on maximal medication. To our delight, numerous attendees commented that when they return home they are planning to speak to their cardiologists and hospitals about the positive effects EECP Therapy can have on their patients.

The attendees were interested to learn more about the clinical evidence recently published by the researchers at the University of Florida in Gainesville demonstrating the positive effects of EECP Therapy on glucose tolerance and insulin resistance.

At the exhibition, we also saw a great deal of interest in our BIOX ECG Holters and ambulatory blood pressure monitors as well as our EZ® pulse oximeters.

We thought the ADA was a successful conference, as we were able to raise awareness for EECP Therapy in this new patient population. We are continuing to learn more about diabetic patients and the potential impact EECP Therapy can have on this patient group’s quality of life.  We hope by next year’s ADA we have even more insight to share!

Next stop: Amsterdam, Netherlands!

Tales from the Road: Hospitalar 2013

After three days of exhibiting at the Hospitalar 2013 meeting in São Paulo, we are even more convinced that Brazil will be an excellent market for EECP Therapy!

At the exhibition, Vasomedical displayed and demonstrated its core technology, EECP Therapy, its Biox ambulatory monitoring products and its EZ series patient management products. Visiting physicians and healthcare professionals expressed particular interest in how EECP technology can help patients with cardiovascular disease as well as significantly reduce healthcare costs.

We met with attendees from across the globe who were extremely pleasant and welcoming to the Vasomedical team and our products. It was a great experience participating in this event and understanding how we can expand our presence in South America.

The icing on the cake: we are in the process of registering Vasomedical and Biox products for sale in Brazil, putting us in a great position to build relationships for the near future!

Make sure to stay tuned for more tales from around the globe as we continue to showcase and educate the healthcare industry about EECP Therapy technology and our other offerings.

Next stop: New York, NY!

EECP Therapy Stars in Medical Thriller: “We Find ‘Em… We Fix ‘Em!”

Upon returning to my office this week I found a copy of a paperback novel on my desk entitled “We Find ‘Em, We Fix ’Em!” written by Richard Ryder MD, a specialist in Internal Medicine and cardiovascular disease currently practicing in Georgia. This book, originally written and published in 2010, is a medical novel that presents a scenario to illustrate in the author’s opinion what he believes is wrong with American healthcare.

More specifically, Dr. Ryder is a physician who, through his writing, challenges both current medical practices and patients to take responsibility for their own healthcare. He is a proponent of preventive cardiology and non-invasive procedures before invasive ones – as are we here at Vasomedical.

By way of a quick summary, the book is about a company executive who experiences what he believes is a heart attack and rushes to Miami General in search of a quick fix. What he gets is a rushed consultation and unnecessary procedure that ultimately “costs him his livelihood, well being, his marriage and almost his life.” The book is touted as a medical thriller based upon research and a carefully imagined scenario, which could happen in reality, about the dangers of unnecessary cardiac procedures and the risks they entail.

After being misdiagnosed and mistreated, the patient sues the doctor.  To us, the most interesting part occurs next:  during the trial Enhanced External Counterpulsation (EECP®) Therapy is brought up in the testimony of a medical expert as a more appropriate therapy than stenting, citing that it should have been considered.

However, it is also pointed out that medical insurances only provide coverage for EECP Therapy when patients cannot be stented or have surgery. This is a very real challenge patients face today.  Though coverage policies are limiting, there are a number of discretionary guidelines that would permit coverage, if in the opinion of a cardiologist or cardiovascular surgeon, the patient is not readily amenable to invasive procedures because of their personal health condition.

Furthermore, EECP is also mentioned as a possible therapy for patients who suffer from congestive heart failure, like the main character who has developed CHF due to his mistreatment. However, it is pointed out that coverage is not currently supported or severely limited for use in this application. I could tell you what happens next but I don’t want to give away any more of the story for those who wish to read the book.

As I flipped through the book, it dawned on me that I wanted to share this story because it is probably happening more often in real life more than we realize. This book could be a great catalyst for greater patient advocacy and support of EECP Therapy, which has helped so many patients to date and saved the healthcare industry a great deal of money, but is still one of the best medical secrets today.

Dr. Ryder was one of the first physicians in the country to be involved with EECP Therapy in his former practice in Johnson City, New York more than a dozen years ago. He is an advocate of EECP Therapy and hopefully is still referring patients to this treatment in his Georgia practice.

You can check out the book here.  Let us know what you think!

Thank you, Dr. Ryder, for helping to bring EECP Therapy to the forefront of conversations.  We hope the rest of you enjoy reading this book as much as I did.

Cleveland Clinic – Non-Invasive Therapy Relieves Chest Pain

Cleveland Clinic featured EECP Therapy on their blog to educate the public on how EECP Therapy can relieve chest pain caused by angina without surgery or medication. You can read the full blog post below.

By: The Beating Edge Team 

Improving blood flow without surgery or medications may seem impossible, but a unique outpatient therapy called Enhanced External Counterpulsation (EECP) is proving effective. It is an option for some patients with unrelieved chest pain caused by angina.

More than 7 million people in the U.S. are estimated to suffer from angina according to the American Heart Association. These patients suffer from ischemia, which means that there is a restriction in the blood supply to body tissues. This causes a shortage of oxygen, and EECP therapy can help.

What Exactly Is EECP?

Enhanced External Counterpulsation is an outpatient therapy that mechanically increases blood flow to improve chest pain symptoms and quality of life.

While undergoing EECP, the patient lies on a comfortable table and is strapped with treatment cuffs that inflate along the legs from the calves to the thighs and buttocks. This external pulsation helps to increase blood supply to the heart muscle and decrease the amount of work it has to do. Throughout the procedure, heart rate and rhythm are monitored to make sure the patient is responding well.

Studies using stress tests have shown that EECP relieves angina and the degree to which a person suffers from ischemia. This non-invasive therapy is provided on an outpatient basis and does not require the use of any medications.

Limitations of EECP

Cleveland Clinic’s Stephen Ellis, MD, section head of Interventional Cardiology, says there are still many reasons that medication and surgical interventions remain the gold standard in heart treatment.

“EECP is not for everyone,” he says. “Some arrhythmias and other cardiovascular conditions preclude EECP, and it takes several treatments to see lasting results—so, the time commitment is great.”

He adds that about half of patients who try EECP relapse after one or two years. In addition, the treatments are not always covered by insurance.

“For some patients, it may be a good option,” says Dr. Ellis, “especially for those who are intolerant of medications or who suffer from persistent angina.”

Is EECP right for you?

The decision to try EECP begins with talking to your physician. EECP has been shown to help patients who:

  • Are no longer getting relief from the use of medications.
  • Have returning symptoms after heart surgery and interventions.
  • Have other health concerns that disqualify them for another procedure.

Learn more about EECP therapy offered at Cleveland Clinic